顺尔宁治疗喘息性支气管炎50例疗效评估  

Evaluate Singulair Asthmatic bronchitis curative effect on treatment of 50 cases

作　　者：陈勇明[1] 

机构地区：[1]广州医科大学附属第四医院,广东广州511447

出　　处：《中医临床研究》2015年第6期37-38,共2页Clinical Journal Of Chinese Medicine

摘　　要：目的:探讨为喘息性支气管炎患儿应用顺尔宁治疗的临床疗效。方法:选取2013年09月—2014年10月我院收治的喘息性支气管炎患儿100例,按硬币法将其分成实验组50例,对照组50例,对照组病例应用雾化吸入普米克令舒吸入治疗,实验组病例在对照组治疗的基础上应用顺尔宁治疗,比较疗效。结果:实验组喘息性支气管炎患儿治疗效果优于对照组,实验组疾病治疗有效率为92.0%,咳喘缓解时间为(48.21±5.21)h,哮鸣音消失时间为(60.15±7.51)h,住院时间为(5.95±0.46)d,以上数据与对照组相比,差异有统计学意义(P<0.05)。结论:为喘息性支气管炎患儿应用顺尔宁治疗,效果满意,顺尔宁临床应用价值高,值得推广。Objective： To investigate the clinical effect of treatment for children with asthmatic bronchitis application singulair. Methods： From 2013 October 09 months to 2014 in our hospital 100 eases of children with asthmatic bronchitis, press the coin method divided into the experimental group 50 cases, control group 50 cases, control group cases application of Pulmicort Respules inhalation in the treatment of montelukast treatment, used in the experimental group were the basis of treatment in control group, comparison curative effect. Results： The experimental group is better than children with asthmatic bronchitis curative effect in control group, the effective rate in experimental group disease treatment is 92%, cough relief time was （48.21 ± 5.21） h, wheeze disappeared time of （60.15 ± 7.51） h, the time of hospitalization for （5.95 ±0.46） d, the above data compared with the control group, the difference was statistically significant （P〈0.05）. Conclusion： For asthmatic bronchitis in children w.ith montelukast treatment application, effect satisfaction, Singulair high clinical application value, worthy of promotion.

关 键 词：顺尔宁 喘息性支气管炎 疗效评估 

分 类 号：R725.6[医药卫生—儿科]